Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells

Langmuir

Volumn 27, Issue 24, 2011, Pages 15024-15033

  Gorelikov, Ivan ^a   Martin, Amanda L ^a   Seo, Minseok ^a,b   Matsuura, Naomi ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL COMPATIBILITY; CANCER CELLS; CDSE/ZNS CORE/SHELL; CONTRAST AGENT; DEPTH PENETRATION; DROPLET INTERACTION; FLUORESCENT QUANTUM DOTS; HIGH SENSITIVITY; HISTOLOGICAL TISSUE; IMAGING PERFORMANCE; IN-VITRO; IN-VIVO; LOWER RESOLUTION; NANO SCALE; OPTICAL METHODS; PERFLUOROCARBONS; ROBUST METHODS; SILICA SURFACE; SINGLE CELLS; SMALL ANIMAL; ULTRASOUND IMAGING;

ANIMALS; BIOCOMPATIBILITY; CELLS; CONDENSATION REACTIONS; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; FLUORESCENT SCREENS; FLUORINE; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; SEMICONDUCTOR QUANTUM DOTS; SILICA; TISSUE; ULTRASONIC IMAGING;

DROPS;

CONTRAST MEDIUM; FLUOROCARBON; NANOPARTICLE; QUANTUM DOT; SILANE DERIVATIVE; SILICON DIOXIDE;

ANIMAL; ARTICLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HALOGENATION; HUMAN; MACROPHAGE; METHODOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; RABBIT; STATIC ELECTRICITY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; FLOW CYTOMETRY; FLUOROCARBONS; HALOGENATION; HUMANS; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; MOLECULAR PROBES; NANOPARTICLES; QUANTUM DOTS; RABBITS; SILANES; SILICON DIOXIDE; STATIC ELECTRICITY;

EID: 83455238691     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la202679p     Document Type: Article

References (76)

1. Clark, L. C.; Gollan, F. Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure Science 1966, 152 (3730) 1755-1756
2. Geyer, R. P. Fluorocarbon-Polyol Artificial Blood Substitutes N. Engl. J. Med. 1973, 289 (20) 1077-1082
3. Sloviter, H. A.; Kamimoto, T. Erythrocyte Substitute for Perfusion of Brain Nature 1967, 216 (5114) 458-460
4. Mitsuno, T.; Ohyanagi, H.; Yokoyama, K.; Suyama, T. Recent Studies on Perfluorochemical (Pfc) Emulsion as an Oxygen Carrier in Japan Biomater. Artif. Cells Artif. Organs 1988, 16 (1-3) 365-373
5. Castro, C. I.; Briceno, J. C. Perfluorocarbon-Based Oxygen Carriers: Review of Products and Trials Artif. Organs 2010, 34 (8) 622-634
6. Maevsky, E.; Ivanitsky, G.; Bogdanova, L.; Axenova, O.; Karmen, N.; Zhiburt, E.; Senina, R.; Pushkin, S.; Maslennikov, I.; Orlov, A.; Marinicheva, I. Clinical results of Perftoran application: Present and future Artif. Cells Blood Substit. Biotechnol. 2005, 33 (1) 37-46 (Pubitemid 40315177)
7. Spahn, D. R.; van Brempt, R.; Theilmeier, G.; Reibold, J. P.; Welte, M.; Heinzerling, H.; Birck, K. M.; Keipert, P. E.; Messmer, K. Perflubron emulsion delays blood transfusions in orthopedic surgery Anesthesiology 1999, 91 (5) 1195-1208 (Pubitemid 29506080)
8. Vorobev, S. I. First- and second-generation perfluorocarbon emulsions Pharm. Chem. J. 2009, 43 (4) 209-218
9. Mattrey, R. F.; Hajek, P. C.; Gylysmorin, V. M.; Baker, L. L.; Martin, J.; Long, D. C.; Long, D. M. Perfluorochemicals as Gastrointestinal Contrast Agents for MR Imaging-Preliminary Studies in Rats and Humans AJR 1987, 148 (6) 1259-1263 (Pubitemid 17083104)
10. Behan, M.; Oconnell, D.; Mattrey, R. F.; Carney, D. N. Perfluorooctylbromide as a Contrast Agent for CT and Sonography-Preliminary Clinical-Results AJR 1993, 160 (2) 399-405 (Pubitemid 23059240)
11. Bruneton, J. N.; Falewee, M. N.; Francois, E.; Cambon, P.; Philip, C.; Riess, J. G.; Balumaestro, C.; Rogopoulos, A. Liver, Spleen, and Vessels-Preliminary Clinical-Results of CT with Perfluorooctylbromide Radiology 1989, 170 (1) 179-183 (Pubitemid 19016871)
12. Mattrey, R. F.; Strich, G.; Shelton, R. E.; Gosink, B. B.; Leopold, G. R.; Lee, T.; Forsythe, J. Perfluorochemicals as US Contrast Agents for Tumor Imaging and Hepatosplenography-Preliminary Clinical-Results Radiology 1987, 163 (2) 339-343 (Pubitemid 17068904)
13. Mattrey, R. F.; Long, D. C. Potential Role of Pfob in Diagnostic-Imaging Invest. Radiol. 1988, 23, S298-S301
14. Riess, J. G. Highly Fluorinated Systems for Oxygen-Transport, Diagnosis and Drug-Delivery Colloids Surf., A 1994, 84 (1) 33-48
15. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 2001, 41, 189-207
16. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: Theory to practice Pharmacological Reviews 2001, 53 (2) 283-318 (Pubitemid 32476118)
17. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharmaceutics 2008, 5 (4) 505-515
18. Gupta, A. K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 2005, 26 (18) 3995-4021 (Pubitemid 40044762)
19. Spahn, D. R.; Waschke, K. F.; Standl, T.; Motsch, J.; Van Huynegem, L.; Welte, M.; Gombotz, H.; Coriat, P.; Verkh, L.; Faithfull, S.; Keipert, P. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery-Results of a European phase 3 study Anesthesiology 2002, 97 (6) 1338-1349 (Pubitemid 35417430)
20. Frank, R.; Hargreaves, R. Clinical biomarkers in drug discovery and development Nat. Rev. Drug Discovery 2003, 2 (7) 566-580 (Pubitemid 37361748)
21. Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.; Felschow, D. The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification Biochem. Biophys. Res. Commun. 2002, 292 (3) 587-592 (Pubitemid 34681100)
22. Nagrath, S.; Sequist, L. V.; Maheswaran, S.; Bell, D. W.; Irimia, D.; Ulkus, L.; Smith, M. R.; Kwak, E. L.; Digumarthy, S.; Muzikansky, A.; Ryan, P.; Balis, U. J.; Tompkins, R. G.; Haber, D. A.; Toner, M. Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 2007, 450 (7173) 1235-1239
23. McCarthy, J. R.; Bhaumik, J.; Karver, M. R.; Erdem, S. S.; Weissleder, R. Targeted nanoagents for the detection of cancers. Mol. Oncol. 4, (6), 511-528.
24. Krafft, M. P.; Riess, J. G. Chemistry, Physical Chemistry, and Uses of Molecular Fluorocarbon-Hydrocarbon Diblocks, Triblocks, and Related Compounds-Unique Apblar Components for Self-Assembled Colloid and Interface Engineering Chem. Rev. 2009, 109 (5) 1714-1792
25. Riess, J. G. Fluorous micro- and nanophases with a biomedical perspective Tetrahedron 2002, 58 (20) 4113-4131 (Pubitemid 34467039)
26. Diaz-Lopez, R.; Tsapis, N.; Fattal, E. Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and F-19-MRI. Pharm. Res. 27 (1), 1-16.
27. Lanza, G. M.; Winter, P. M.; Caruthers, S. D.; Hughes, M. S.; Cyrus, T.; Marsh, J. N.; Neubauer, A. M.; Partlow, K. C.; Wickline, S. A. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles Nanomedicine 2006, 1 (3) 321-329
28. Morawski, A. M.; Lanza, G. A.; Wickline, S. A. Targeted contrast agents for magnetic resonance imaging and ultrasound Curr. Opin. Biotechnol. 2005, 16 (1) 89-92 (Pubitemid 40249763)
29. Riess, J. G. Blood substitutes and other potential biomedical applications of fluorinated colloids J. Fluorine Chem. 2002, 114 (2) 119-126
30. Riess, J. G.; Leblanc, M. Solubility and Transport Phenomena in Perfluorochemicals Relevant to Blood Substitution and Other Biomedical Applications Pure Appl. Chem. 1982, 54 (12) 2383-2406 (Pubitemid 13139610)
31. Riess, J. G. Oxygen carriers (blood substitutes)-Raison dEtre, chemistry, and some physiology Chem. Rev. 2001, 101 (9) 2797-2919 (Pubitemid 35377808)
32. Rapoport, N.; Pitt, W. G.; Sun, H.; Nelson, J. L. Drug delivery in polymeric micelles: from in vitro to in vivo J. Controlled Release 2003, 91 (1-2) 85-95 (Pubitemid 37288879)
33. Pisani, E.; Tsapis, N.; Paris, J.; Nicolas, V.; Cattel, L.; Fattal, E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization Langmuir 2006, 22 (9) 4397-4402
34. Kripfgans, O. D.; Fowlkes, J. B.; Miller, D. L.; Eldevik, O. P.; Carson, P. L. Acoustic droplet vaporization for therapeutic and diagnostic applications Ultrasound Med. Biol. 2000, 26 (7) 1177-1189
35. Anderson, S. A.; Rader, R. K.; Westlin, W. F.; Null, C.; Jackson, D.; Lanza, C. M.; Wickline, S. A.; Kotyk, J. J. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles Magn. Reson. Med. 2000, 44 (3) 433-439
36. Lanza, G. M.; Wallace, K. D.; Scott, M. J.; Cacheris, W. P.; Abendschein, D. R.; Christy, D. H.; Sharkey, A. M.; Miller, J. G.; Gaffney, P. J.; Wickline, S. A. A novel site-targeted ultrasonic contrast agent with broad biomedical application Circulation 1996, 94 (12) 3334-3340 (Pubitemid 26427506)
37. Winter, P. M.; Morawski, A. M.; Caruthers, S. D.; Fuhrhop, R. W.; Zhang, H. Y.; Williams, T. A.; Allen, J. S.; Lacy, E. K.; Robertson, J. D.; Lanza, G. M.; Wickline, S. A. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta(3)-Integrin-targeted nanoparticles Circulation 2003, 108 (18) 2270-2274 (Pubitemid 37363046)
38. Yu, X.; Song, S. K.; Chen, J. J.; Scott, M. J.; Fuhrhop, R. J.; Hall, C. S.; Gaffney, P. J.; Wickline, S. A.; Lanza, G. M. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent Magn. Reson. Med. 2000, 44 (6) 867-872
39. Riess, J. G. Reassessment of Criteria for the Selection of Perfluorochemicals for 2nd-Generation Blood Substitutes-Analysis of Structure Property Relationships Artif. Organs 1984, 8 (1) 44-56 (Pubitemid 14126441)
40. Kawabata, K.-i.; Asami, R.; Azuma, T.; Yoshikawa, H.; Umemura, S.-i. Cavitation ssisted HIFU with phase-change nano droplet; In Proceedings of the IEEE Ultrasonic Symposium 2008; pp 780-783.
41. Kripfgans, O. D.; Fowlkes, J. B.; Woydt, M.; Eldevik, O. P.; Carson, P. L. In vivo droplet vaporization for occlusion therapy and phase aberration correction IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 2002, 49 (6) 726-738 (Pubitemid 34773069)
42. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharmaceutics 2008, 5 (4) 487-495
43. Weissleder, R.; Pittet, M. J. Imaging in the era of molecular oncology Nature 2008, 452 (7187) 580-589 (Pubitemid 351483372)
44. Li, J. J.; Wang, Y. A.; Guo, W. Z.; Keay, J. C.; Mishima, T. D.; Johnson, M. B.; Peng, X. G. Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction J. Am. Chem. Soc. 2003, 125 (41) 12567-12575 (Pubitemid 37254773)
45. Yi, D. K.; Selvan, S. T.; Lee, S. S.; Papaefthymiou, G. C.; Kundaliya, D.; Ying, J. Y. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots J. Am. Chem. Soc. 2005, 127 (14) 4990-4991 (Pubitemid 40523437)
46. Nikoobakht, B.; El-Sayed, M. A. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method Chem. Mater. 2003, 15 (10) 1957-1962
47. Gorelikov, I.; Matsuura, N. Single-step coating of mesoporous silica on cetyltrimethyl ammonium bromide-capped nanoparticles Nano Lett. 2008, 8 (1) 369-373 (Pubitemid 351177829)
48. Yu, W. W.; Qu, L. H.; Guo, W. Z.; Peng, X. G. Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals Chem. Mater. 2003, 15 (14) 2854-2860
49. Xia, Y. N.; Whitesides, G. M. Soft lithography Angew. Chem., Int. Ed. 1998, 37 (5) 551-575 (Pubitemid 28214103)
50. Seo, M.; Gorelikov, I.; Williams, R.; Matsuura, N. Microfluidic Assembly of Monodisperse, Nanoparticle-Incorporated Perfluorocarbon Microbubbles for Medical Imaging and Therapy. Langmuir 26 (17), 13855-13860.
51. Babiak, P.; Nemcova, A.; Rulisek, L.; Beier, P. On the miscibility of ethers and perfluorocarbons an experimental and theoretical study J. Fluorine Chem. 2008, 129 (5) 397-401
52. Bruchez, M.; Moronne, M.; Gin, P.; Weiss, S.; Alivisatos, A. P. Semiconductor nanocrystals as fluorescent biological labels Science 1998, 281 (5385) 2013-2016 (Pubitemid 28475485)
53. Hsiao, J. K.; Tsai, C. P.; Chung, T. H.; Hung, Y.; Yao, M.; Liu, H. M.; Mou, C. Y.; Yang, C. S.; Chen, Y. C.; Huang, D. M. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking Small 2008, 4 (9) 1445-1452
54. Huang, X. H.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods J. Am. Chem. Soc. 2006, 128 (6) 2115-2120 (Pubitemid 43277351)
55. Kim, H. J.; Matsuda, H.; Zhou, H. S.; Honma, I. Ultrasound-triggered smart drug release from a poly(dimethylsiloxane)-mesoporous silica composite Adv. Mater. 2006, 18 (23) 3083-3088 (Pubitemid 46080197)
56. Lu, C. W.; Hung, Y.; Hsiao, J. K.; Yao, M.; Chung, T. H.; Lin, Y. S.; Wu, S. H.; Hsu, S. C.; Liu, H. M.; Mou, C. Y.; Yang, C. S.; Huang, D. M.; Chen, Y. C. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling Nano Lett. 2007, 7 (1) 149-154 (Pubitemid 46225844)
57. Neuberger, T.; Schopf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system J. Magn. Magn. Mater. 2005, 293 (1) 483-496 (Pubitemid 40608969)
58. Slowing, II; Vivero-Escoto, J. L.; Wu, C. W.; Lin, V. S. Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Delivery Rev. 2008, 60 (11) 1278-1288
59. Trewyn, B. G.; Giri, S.; Slowing, II; Lin, V. S. Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems Chem. Commun. 2007, 31, 3236-3245 (Pubitemid 47197838)
60. Zhang, C.; Wangler, B.; Morgenstern, B.; Zentgraf, H.; Eisenhut, M.; Untenecker, H.; Kruger, R.; Huss, R.; Seliger, C.; Semmler, W.; Kiessling, F. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: A promising tool to label cells for magnetic resonance imaging Langmuir 2007, 23 (3) 1427-1434
61. Lim, Y. T.; Noh, Y. W.; Cho, J. H.; Han, J. H.; Choi, B. S.; Kwon, J.; Hong, K. S.; Gokarna, A.; Cho, Y. H.; Chung, B. H. Multiplexed Imaging of Therapeutic Cells with Multispectrally Encoded Magnetofluorescent Nanocomposite Emulsions J. Am. Chem. Soc. 2009, 131 (47) 17145-17154
62. Lim, Y. T.; Cho, M. Y.; Kang, J. H.; Noh, Y. W.; Cho, J. H.; Hong, K. S.; Chung, J. W.; Chung, B. H. Perfluorodecalin/[InGaP/ZnS quantum dots] nanoemulsions as F-19 MR/optical imaging nanoprobes for the labeling of phagocytic and nonphagocytic immune cells. Biomaterials 31 (18), 4964-4971.
63. Aldana, J.; Wang, Y. A.; Peng, X. G. Photochemical instability of CdSe nanocrystals coated by hydrophilic thiols J. Am. Chem. Soc. 2001, 123 (36) 8844-8850 (Pubitemid 32852687)
64. Stober, W.; Fink, A.; Bohn, E. Controlled Growth of Monodisperse Silica Spheres in Micron Size Range J. Colloid Interface Sci. 1968, 26 (1) 62
65. Brinker, C. J.; Scherer, G. W. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing; Academic Press: New York, 1990.
66. Prabakar, S.; Assink, R. A. Hydrolysis and condensation kinetics of two component organically modified silica sols J. Non-Cryst. Solids 1997, 211 (1-2) 39-48 (Pubitemid 127417209)
67. Sinha, R.; Kim, G. J.; Nie, S. M.; Shin, D. M. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol. Cancer Ther. 2006, 5 (8) 1909-1917 (Pubitemid 44336561)
68. Nie, S. M.; Xing, Y.; Kim, G. J.; Simons, J. W. Nanotechnology applications in cancer Annu. Rev. Biomed. Eng. 2007, 9, 257-288 (Pubitemid 350246658)
69. Rosen, M. J. Surfactants and interfacial phenomena, 3 rd ed.; John Wiley & Sons, Inc.: Hoboken, 2004; p 444.
70. Matsuura, N.; Rowlands, J. A. Towards new functional nanostructures for medical imaging Medical Physics 2008, 35 (10) 4474-4487
71. Kornmann, L. M.; Curfs, D. M. J.; Hermeling, E.; van der Made, I.; de Winther, M. P. J.; Reneman, R. S.; Reesink, K. D.; Hoeks, A. P. G. Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: A feasibility study Mol. Imag. Biol. 2008, 10 (5) 264-270
72. Mattrey, R. F.; Long, D. M.; Multer, F.; Mitten, R.; Higgins, C. B. Perfluoroctylbromide-a Reticuloendothelial-Specific and Tumor-Imaging Agent for Computed-Tomography Radiology 1982, 145 (3) 755-758
73. Emonard, H. P.; Remacle, A. G.; Noel, A. C.; Grimaud, J. A.; Stetlerstevenson, W. G.; Foidart, J. M. Tumor-Cell Surface-Associated Binding-Site for the M(R)72,000 Type-Iv Collagenase Cancer Res. 1992, 52 (20) 5845-5848
74. Fong, S.; Itahana, Y.; Sumida, T.; Singh, J.; Coppe, J. P.; Liu, Y.; Richards, P. C.; Bennington, J. L.; Lee, N. M.; Debs, R. J.; Desprez, P. Y. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (23) 13543-13548 (Pubitemid 37444778)
75. Shenoy, D.; Little, S.; Langer, R.; Amiji, M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations Mol. Pharmaceutics 2005, 2 (5) 357-366 (Pubitemid 41503676)
76. Mattrey, R. F.; Scheible, F. W.; Gosink, B. B.; Leopold, G. R.; Long, D. M.; Higgins, C. B. Perfluoroctylbromide-a Liver Spleen-Specific and Tumor-Imaging Ultrasound Contrast Material Radiology 1982, 145 (3) 759-762